Teacher Retirement System of Texas Has $66.49 Million Stake in Cigna Group $CI

Teacher Retirement System of Texas boosted its position in Cigna Group (NYSE:CIFree Report) by 79.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 201,138 shares of the health services provider’s stock after buying an additional 89,054 shares during the period. Teacher Retirement System of Texas’ holdings in Cigna Group were worth $66,492,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of CI. Flaharty Asset Management LLC acquired a new position in Cigna Group in the first quarter valued at $28,000. 1248 Management LLC bought a new stake in Cigna Group in the first quarter valued at $29,000. Solstein Capital LLC bought a new stake in Cigna Group in the second quarter valued at $29,000. Activest Wealth Management increased its stake in Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC bought a new stake in Cigna Group in the second quarter valued at $30,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity

In related news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

CI has been the subject of several research analyst reports. Guggenheim reaffirmed a “buy” rating and issued a $350.00 price target (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Wolfe Research decreased their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, October 15th. Truist Financial set a $375.00 price target on shares of Cigna Group in a research note on Tuesday, September 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $365.00 price target on shares of Cigna Group in a research note on Tuesday, August 26th. Finally, Barclays lifted their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $369.89.

View Our Latest Research Report on CI

Cigna Group Trading Down 1.1%

NYSE:CI opened at $301.84 on Monday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a 50-day moving average of $299.22 and a 200-day moving average of $307.54. The company has a market cap of $80.57 billion, a PE ratio of 16.48, a PEG ratio of 0.88 and a beta of 0.45. Cigna Group has a one year low of $256.89 and a one year high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping the consensus estimate of $7.15 by $0.05. The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a dividend of $1.51 per share. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group’s payout ratio is 32.97%.

Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.